Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

Company Update

8 Apr 2020 07:00

RNS Number : 1324J
Marble Point Loan Financing Limited
08 April 2020
 

 

8 April 2020

 

Marble Point Loan Financing Limited

COVID-19 and Q1 2020 dividend update

 

Marble Point Loan Financing Limited ("the Company" or "MPLF"), today issues an update on the impact of COVID-19 and its Q1 2020 dividend.

As detailed in the Company's previous monthly reports, the quarterly cash distributions from its portfolio of CLO Equity, CLO Debt and other related investments have increased over the past several quarters. These quarterly distributions have funded Company cumulative dividend payments of approximately $0.155 per share since the IPO and other cash uses including new investments. Further, in each of the past five quarters, portfolio cash distributions exceeded the quarterly dividend by a sound margin, in-line with the Board's expectations in normal market conditions.

Given the ongoing uncertainty caused by the COVID-19 pandemic, however, the Board has resolved to temporarily suspend the declaration of dividends. The Board and the Investment Manager recognise the importance of dividends for Shareholders but believe preserving liquidity is the appropriate and prudent action considering the significant near-term uncertainties that exist.

The COVID-19 pandemic and its unprecedented economic disruption have seen rating agencies downgrade CLOs' underlying senior secured loan collateral at an accelerating pace which increases the risk of triggering provisions of CLOs' tests which could impact near-term cash flows. Additionally, the heightened risk of higher than modeled default rates may impact the portion of distributions ascribed to income under the Company's effective yield methodology, thereby potentially affecting the magnitude of cash flows.

It is difficult to predict the full impact of the COVID-19 pandemic on loan and CLO markets, but the Company remains focused on delivering long term value to shareholders and taking prudent actions in the near term in respect of this quickly changing market dynamic.

The Investment Manager believes the dislocation in credit markets may also create attractive investment opportunities beneficial to future investment portfolio cash distributions, with the goal of seeking to maximise shareholders' total return over the long term. The Company believes it is well positioned to take advantage of such dislocation. To the extent that income generated by the CLOs is not distributed but is available for reinvestment into additional collateral within the CLOs, given the current loan market environment, such reinvestment activities may build par and enhance potential distributions from the CLOs in the future.

In the event that cash flows in the near term are not impacted or should conditions in the loan market improve, the Board will consider the reinstatement of the quarterly dividend and other appropriate options.

The Board will, in consultation with the Investment Manager monitor these developments and the performance of the Company's investments and make further announcements as appropriate.

Robert Brown, Chairman of Marble Point Loan Financing, commented:

"With an average of over 29 years' experience in leveraged credit markets, the Investment Manager's senior management team has invested through several previous market dislocations. MPLF's Board of Directors has confidence in the Investment Manager's ability to manage the Company's investments through this period and deliver long-term value for shareholders."

 

Past performance is not indicative, or a guarantee, of future performance.

This release contains inside information.

Enquiries:

Marble Point Loan Financing Limited

Investor Relations

T: +44 (0) 20 7259 1500

E: ir@mplflimited.com 

Website: www.mplflimited.com 

Corporate Broker:

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

Financial Public Relations:

Charlie Barker / Catherine Chapman

MHP Communications

T: +44 (0) 20 3128 8100

MarblePoint@mhpc.com

 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey closed-ended investment company with its ordinary shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (tickers: MPLF LN / MPLS LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC or its affiliates. For more information, please visit the Company's website: www.mplflimited.com.

LEI: 549300DWXSN5UC85CL26

 

ABOUT MARBLE POINT CREDIT MANAGEMENT LLC

Marble Point Credit Management LLC ("Marble Point") is a specialist asset manager focused exclusively on leveraged loans. Marble Point was founded by Thomas Shandell in partnership with Eagle Point Credit Management, a leading investor in CLO securities. As at 31 March 2020, Marble Point manages approximately $5.3 billion of assets across CLOs and other managed accounts.

 

IMPORTANT INFORMATION

This document is provided for informational purposes only and does not constitute an offer to sell any shares, notes or other securities (collectively, "Securities") issued by the Company or a solicitation of an offer to purchase any such Securities in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction. This document may not be relied upon, and should not be used, for the purpose of making any investment decision. The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940 and investors will not be entitled to the benefits of such Act.

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSSFFUWESSEFL
Date   Source Headline
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th Jan 20236:00 pmRNSDividend Declaration
12th Jan 20236:17 pmRNSMPLF Director / PDMR Shareholding
12th Jan 20236:00 pmRNSCompany Investment Manager Acquired by Investcorp
10th Jan 20236:00 pmRNSHolding(s) in Company
28th Dec 20226:00 pmRNSDividend Declaration
22nd Dec 20226:30 pmRNSNotice of Ordinary Share Re-designation
22nd Dec 20226:30 pmRNSChanges to the Board of Directors
21st Dec 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
2nd Dec 20227:30 amRNSCompany Investment Manager Agrees to Combination
22nd Nov 20226:00 pmRNS3rd Quarter Results
22nd Nov 20227:00 amRNSNet Asset Value & Publication of Monthly Report
17th Nov 20227:00 amRNSResults of General Meeting
17th Nov 20227:00 amRNSResults of Annual General Meeting
26th Oct 20227:00 amRNSNotice of Annual General Meeting
25th Oct 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Oct 20226:00 pmRNSSterling Dividend Amount
29th Sep 20227:00 amRNSDividend Declaration
21st Sep 20227:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20226:00 pmRNSHalf-Year Report
19th Aug 20227:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jul 20227:00 amRNSIssue of Equity
22nd Jul 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Jul 20226:00 pmRNSDividend Declaration
15th Jul 20227:00 amRNSPublication of Key Investor Document
30th Jun 20227:00 amRNSDividend Declaration
23rd Jun 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Jun 20227:00 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th Jun 20225:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.